{"id":"W4391527398","doi":"10.1016/j.esmoop.2024.102233","title":"Trastuzumab deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"ESMO Open","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"European Society for Medical Oncology; Canada Excellence Research Chairs, Government of Canada; Innovent Biologics; Incyte; Exelixis; AstraZeneca; Amgen; Pfizer; Daiichi Sankyo Europe; Actuate Therapeutics; Bristol-Myers Squibb","keywords":"Medicine; Trastuzumab; Internal medicine; Oncology; Meta-analysis; Breast cancer; Confidence interval; Observational study; Cochrane Library; Cancer; Clinical trial; Hazard ratio; Population","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001986587,0.001246841,0.01874796,0.0007554571,0.0001309841,0.0002928574,0.0005927394,0.0002383525,0.006191993],"category_scores_gemma":[0.00018285,0.0007079962,0.003994171,0.001969632,0.0001056352,0.0002209194,0.0004738623,0.0007254725,0.0001129002],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006858464,"about_ca_system_score_gemma":0.000529333,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006642325,"about_ca_topic_score_gemma":0.001924132,"domain_scores_codex":[0.992895,0.002406366,0.002184829,0.001440234,0.000514736,0.000558836],"domain_scores_gemma":[0.997004,0.0005540789,0.0008706814,0.001029684,0.0001448877,0.0003966914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.000007532895,0.0002060163,0.000002540431,0.641803,0.3497948,0.0003615972,0.00009302928,6.607397e-8,2.337105e-8,0.0001840735,0.002287601,0.005259749],"study_design_scores_gemma":[0.0004174442,0.0001302828,0.00002792432,0.09691323,0.8828326,0.0004176584,0.00003929962,6.686367e-7,5.247068e-7,0.00001813076,0.01866443,0.0005378043],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000001361627,0.9715992,0.00001362002,0.003514407,0.00004220525,0.01339739,0.01120997,0.00003822989,0.0001836403],"genre_scores_gemma":[0.00008362169,0.9857508,0.0003636375,0.001798212,0.00004900387,0.007098208,0.002002458,0.0001465786,0.002707464],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5448897,"threshold_uncertainty_score":0.9999725,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1035190228253845,"score_gpt":0.4221861749337481,"score_spread":0.3186671521083637,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}